摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-羟基哌啶-1-甲基)-苯甲腈 | 887593-88-6

中文名称
4-(4-羟基哌啶-1-甲基)-苯甲腈
中文别名
4-[(4-羟基-1-哌啶基)甲基]苯腈;4-(4-羟基-哌啶-1-基甲基)-苯甲腈
英文名称
1-(4-cyanobenzyl)piperidin-4-ol
英文别名
4-((4-Hydroxypiperidin-1-yl)methyl)benzonitrile;4-[(4-hydroxypiperidin-1-yl)methyl]benzonitrile
4-(4-羟基哌啶-1-甲基)-苯甲腈化学式
CAS
887593-88-6
化学式
C13H16N2O
mdl
MFCD06656916
分子量
216.283
InChiKey
NYAOZPISCGYEAV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.17

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.461
  • 拓扑面积:
    47.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Trypanocidal Activity of Conformationally Restricted Pentamidine Congeners
    摘要:
    A series of conformationally restricted congeners of pentamidine in which the flexible pentyl bridge of pentamidine was replaced by trans-1,2-bismethylenecyclopropyl, phenyl, pyridinyl, piperazinyl, homopiperazinyl, and piperidinyl groups were synthesized. The compounds were evaluated for trypanocidal activity in vitro and in vivo against one drug-sensitive and three drug-resistant trypanosome isolates. The DNA binding affinity of the compounds was also studied using calf thymus DNA and poly(dA-dT). The nature of the linker influenced the DNA binding affinity as well as the trypanocidal activity of the compounds. trans-1,2-Bis(4-amidinophenoxymethylene)cyclopropane (1) was over 25-fold more potent than pentamidine against the drug-resistant isolate KETRI 243As-10-3, albeit with comparable DNA binding affinity. NN'-Bis(4-amidinophenyl)homopiperazine (8) was the most potent trypanocide in vitro against all four trypanosome isolates studied, but N,N'-bis(4-amidinophenyl)piperazine (6) was the most effective agent in vivo against both drug-sensitive and drug-resistant trypanosomes.
    DOI:
    10.1021/jm020375q
  • 作为产物:
    描述:
    4-羟基哌啶对氰基溴化苄N,N-二异丙基乙胺 作用下, 以 四氢呋喃 为溶剂, 以97%的产率得到4-(4-羟基哌啶-1-甲基)-苯甲腈
    参考文献:
    名称:
    Trypanocidal Activity of Conformationally Restricted Pentamidine Congeners
    摘要:
    A series of conformationally restricted congeners of pentamidine in which the flexible pentyl bridge of pentamidine was replaced by trans-1,2-bismethylenecyclopropyl, phenyl, pyridinyl, piperazinyl, homopiperazinyl, and piperidinyl groups were synthesized. The compounds were evaluated for trypanocidal activity in vitro and in vivo against one drug-sensitive and three drug-resistant trypanosome isolates. The DNA binding affinity of the compounds was also studied using calf thymus DNA and poly(dA-dT). The nature of the linker influenced the DNA binding affinity as well as the trypanocidal activity of the compounds. trans-1,2-Bis(4-amidinophenoxymethylene)cyclopropane (1) was over 25-fold more potent than pentamidine against the drug-resistant isolate KETRI 243As-10-3, albeit with comparable DNA binding affinity. NN'-Bis(4-amidinophenyl)homopiperazine (8) was the most potent trypanocide in vitro against all four trypanosome isolates studied, but N,N'-bis(4-amidinophenyl)piperazine (6) was the most effective agent in vivo against both drug-sensitive and drug-resistant trypanosomes.
    DOI:
    10.1021/jm020375q
点击查看最新优质反应信息

文献信息

  • [EN] CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS<br/>[FR] COMPOSÉS DE CARBOXAMIDE, DE SULFONAMIDE ET D'AMINE POUR DES TROUBLES MÉTABOLIQUES
    申请人:RIGEL PHARMACEUTICALS INC
    公开号:WO2009065131A1
    公开(公告)日:2009-05-22
    Disclosed are carboxamide, sulfonamide and amine compounds, as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R1, R2, R4, E, T, n and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    揭示了羧酰胺、磺胺酰胺和胺化合物,以及药物组合物和使用方法。其中一种实施例是具有以下结构的化合物,其中R1、R2、R4、E、T、n和x如本文所述。在某些实施例中,本文所披露的化合物可以激活AMPK途径,并可用于治疗与代谢有关的疾病和症状。
  • AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same
    申请人:Hong Hui
    公开号:US20120115838A1
    公开(公告)日:2012-05-10
    Disclosed are carboxamide, sulfonamide and amine compounds, as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R 1 , R 2 , R 4 , E, T, n and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    本发明涉及羧酰胺、磺酰胺和胺类化合物,以及药物组合物和使用方法。其中一种实施方式是具有以下结构的化合物,其中R1、R2、R4、E、T、n和x如本文所述。在某些实施方式中,本文所披露的化合物可以激活AMPK通路,并可用于治疗代谢相关的疾病和症状。
  • Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
    申请人:Hong Hui
    公开号:US20090170829A1
    公开(公告)日:2009-07-02
    Disclosed are carboxamide, sulfonamide and amine compounds, as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R 1 , R 2 , R 4 , E, T, n and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    本发明涉及羧酰胺、磺酰胺和胺化合物,以及制备药物组合物和使用方法。其中一种实施方式是具有下列结构的化合物: 其中R1、R2、R4、E、T、n和x的定义如本文所述。在某些实施方式中,本文所披露的化合物可以激活AMPK途径,并可用于治疗与代谢有关的疾病和症状。
  • Synthesis and anti-pneumocystis carinii activity of piperidine-linked aromatic diimidazolines
    作者:Tien L. Huang、Qian Zhang、Angele T. White、Sherry F. Queener、Marilyn S. Bartlett、James W. Smith、Isaac O. Donkor
    DOI:10.1016/0960-894x(96)00373-3
    日期:1996.9
    A series of novel piperidine-linked aromatic diimidazolines (3-7) have been synthesized as conformationally restricted congeners of the anti-Pneumocystis carinii drug, Pentamidine. These compounds significantly inhibited the growth of Pneumocystis carinii in culture at 1 mu g/mL. Copyright (C) 1996 Elsevier Science Ltd
  • CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS
    申请人:Rigel Pharmaceuticals, Inc.
    公开号:EP2231600A1
    公开(公告)日:2010-09-29
查看更多